1. Home
  2. MDGL vs UPST Comparison

MDGL vs UPST Comparison

Compare MDGL & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • UPST
  • Stock Information
  • Founded
  • MDGL 2011
  • UPST 2012
  • Country
  • MDGL United States
  • UPST United States
  • Employees
  • MDGL N/A
  • UPST N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • UPST Finance: Consumer Services
  • Sector
  • MDGL Health Care
  • UPST Finance
  • Exchange
  • MDGL Nasdaq
  • UPST Nasdaq
  • Market Cap
  • MDGL 6.1B
  • UPST 5.5B
  • IPO Year
  • MDGL N/A
  • UPST 2020
  • Fundamental
  • Price
  • MDGL $427.10
  • UPST $52.73
  • Analyst Decision
  • MDGL Strong Buy
  • UPST Buy
  • Analyst Count
  • MDGL 10
  • UPST 14
  • Target Price
  • MDGL $485.78
  • UPST $76.04
  • AVG Volume (30 Days)
  • MDGL 294.9K
  • UPST 8.0M
  • Earning Date
  • MDGL 10-30-2025
  • UPST 11-04-2025
  • Dividend Yield
  • MDGL N/A
  • UPST N/A
  • EPS Growth
  • MDGL N/A
  • UPST N/A
  • EPS
  • MDGL N/A
  • UPST N/A
  • Revenue
  • MDGL $515,547,000.00
  • UPST $884,807,000.00
  • Revenue This Year
  • MDGL $394.08
  • UPST $59.39
  • Revenue Next Year
  • MDGL $61.80
  • UPST $27.34
  • P/E Ratio
  • MDGL N/A
  • UPST N/A
  • Revenue Growth
  • MDGL 3421.98
  • UPST 53.62
  • 52 Week Low
  • MDGL $200.63
  • UPST $31.40
  • 52 Week High
  • MDGL $463.63
  • UPST $96.43
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 50.64
  • UPST 34.39
  • Support Level
  • MDGL $425.60
  • UPST $50.20
  • Resistance Level
  • MDGL $463.63
  • UPST $54.13
  • Average True Range (ATR)
  • MDGL 14.91
  • UPST 2.79
  • MACD
  • MDGL -4.55
  • UPST -0.23
  • Stochastic Oscillator
  • MDGL 20.84
  • UPST 17.06

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About UPST Upstart Holdings Inc.

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.

Share on Social Networks: